'Groundbreaking' Potential Lupus Cure Sends Patients into Remission, Allowing Dreams to Be Fulfilled

Key Points:

• A recent UK trial of CAR T-cell therapy, previously successful in cancer treatment, has induced remission in five lupus patients, including one who fulfilled her dream of Alpine skiing.
• Lupus, an autoimmune disorder affecting 1.5 million Americans, causes the immune system to attack healthy organs like kidneys; the trial targeted lupus nephritis, a severe lupus-related kidney condition.
• Of nine patients treated at University College London Hospital, five receiving a lower dose of CAR T-cell therapy went into remission within three months and maintained it over an 11-month follow-up.
• Professor Karl Peggs highlighted the groundbreaking nature of these findings, suggesting that CAR T-cell therapy could potentially cure lupus by resetting the immune system, pending confirmation in larger studies.
• Patient Katie Tinkler described the treatment as life-changing, noting significant health improvements and a dramatic positive impact on her quality of life.